Home » Topics » BioWorld Science

BioWorld Science
RSS

Universidad de Salamanca reveals LL-15

June 21, 1996

Breast/prostate cancer treatment agents reported

June 21, 1996

Development of DS-4152 for Kaposi's sarcoma in AIDS patients terminated

June 21, 1996

Potential cancer/nephritis derivatives reported

June 21, 1996

Multikine covered under Japanese patent

June 21, 1996

Positive preclinical results for Onconase reported

June 21, 1996

LHRH antagonists disclosed by Takeda

June 21, 1996

Antitumor baccatin derivatives from Tanabe Seiyaku

June 21, 1996

DX-8951f enters phase I

June 21, 1996

Camptosar approved in U.S.

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...